Safety Evaluation of Use Sodic Enoxaparin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study was to evaluate safety, not inferiority clinical and pharmacodynamic profile of the drug Enoxaparin Sodium produced by laboratory Blausiegel when compared with Clexane product, produced by Laboratory Sanofi-Aventis in 60 patients with Chronic Renal Desease.
Epistemonikos ID: cab37a4acf95c64fd2b67ec6132f8cff7e01cbc4
First added on: May 05, 2024